Correction to: CNS Drugs 10.1007/s40263-019-00626-2
An Online First version of this article was made available online at http://link.springer.com/journal/40263/onlineFirst/page/1 on 8 April 2019. An error was subsequently identified in the article, and the following correction should be noted:
Section 2.3 (Trial Design), sentence 2- the text that read:
During the study, subjects received three 28-day cycles of daily combined oral contraceptive (21 days of ethinylestradiol 0.025 mg/norgestimate 0.25 mg followed by inert ingredients for 7 days) (Fig. 1).
Should read:
During the study, subjects received three 28-day cycles of daily combined oral contraceptive (21 days of ethinylestradiol 0.035 mg/norgestimate 0.25 mg followed by inert ingredients for 7 days) (Fig. 1).